Clinical Trials Logo

Filter by:
NCT ID: NCT05266833 Completed - Anxiety Clinical Trials

Breathing for Adolescent Stress Reduction Feasibility RCT

Start date: January 20, 2021
Phase: N/A
Study type: Interventional

The purpose of this study was to test a simple slow breathing curriculum for reducing stress among high school students. The curriculum was developed by the Health and Human Performance Foundation and implemented for this study at a public high school in Colorado, United States.

NCT ID: NCT05266716 Completed - Clinical trials for Methamphetamine Abuse

Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder

Start date: February 18, 2021
Phase: N/A
Study type: Interventional

The overall purpose of the observational, investigational pilot study is to assess the clinical utility of the Affect digital health platform (the Affect® "app") as part of the Affect program of treatment for methamphetamine-primary stimulant use disorder. The study also will identify elements of the Affect app that enhance engagement of participants in the study toward the goal of improving patient outcomes, including reduction/cessation of stimulant use.

NCT ID: NCT05266586 Completed - Clinical trials for Hypercholesterolemia

Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy

ROSE2
Start date: March 9, 2022
Phase: Phase 2
Study type: Interventional

This study will be a placebo-controlled, double-blind, randomized, phase 2 study to evaluate the efficacy, safety, and tolerability of obicetrapib 10 mg, both in combination with ezetimibe 10 mg and as monotherapy, as an adjunct to high-intensity statin therapy.

NCT ID: NCT05266573 Completed - Fall Clinical Trials

Exercise for Adults With Limited Mobility

Start date: January 8, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of a structured and progressive task-oriented, community based exercise program for older adults who have limitations in mobility and examine whether improvements in mobility and quality of life would be seen following completion at 6 months.

NCT ID: NCT05266456 Completed - Clinical trials for Pneumococcal Vaccines

Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults

Start date: February 22, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The objective of the study is to evaluate the safety and tolerability of a single injection of VAX-24 at 3 dose levels compared to Prevnar 20™ (PCV20) in adults 18 to 49 years of age in Phase 1. The Phase 2 will evaluate the safety, tolerability, and immunogenicity of a single injection of VAX-24 at 3 dose levels compared to PCV20 in adults aged 50 to 64 years of age in Phase 2.

NCT ID: NCT05266248 Completed - Pharmacokinetics Clinical Trials

Pilot Study Characterizing the Pharmacokinetic Profile of a Novel Encapsulated Caffeine Beverage in the Fed and Fasted States

Start date: January 25, 2022
Phase: Phase 1
Study type: Interventional

Pilot study designed to characterize the plasma caffeine pharmacokinetic profile of encapsulated caffeine when consumed in the fasted and fed states.

NCT ID: NCT05266183 Completed - Eating Behavior Clinical Trials

Combined Effects of Simultaneous Variety and Portion Size on Meal Intake of Women

Start date: March 7, 2022
Phase: N/A
Study type: Interventional

The primary purpose of this study is to investigate the combined effects of simultaneous meal variety and portion size on food intake at a meal. Additionally, other individual characteristics will be examined for their influence on the effects of simultaneous variety and portion size on meal intake.

NCT ID: NCT05266053 Completed - Clinical trials for Hypertrophic Skin Condition of Anterior Abdomen

Negative Pressure Wound Therapy-PICO: Cosmesis in Repeat C-Sections

Start date: July 28, 2022
Phase: N/A
Study type: Interventional

There are millions of births each year with 32% of women undergoing cesarean sections (C-sections), which results in skin scarring. Repeat C-sections increased by 178% from 1979-2010. Given the frequency of C-sections, it is important to achieve a desirable cosmetic outcome. The PICO 7 dressing consists of a negative pressure wound therapy pump (NPWT) connected to an absorbent gentle adhesive dressing that is applied to a wound. When the pump is activated, it acts by pulling excess fluid from the wound. The dressing absorbs this fluid and helps to prevent bacteria from entering the wound. It has been shown to prevent wound infections and promote healing. This study aims to compare the aesthetic appearance by using The Patient and Observer Scar Assessment Scale (POSAS) scar assessment scale following closed incision negative pressure therapy with a PICO 7 dressing to the standard abdominal dressing in women undergoing repeat cesarean sections

NCT ID: NCT05265910 Completed - Clinical trials for Allergic Conjunctivitis

A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis

Start date: December 14, 2021
Phase: Phase 4
Study type: Interventional

This is a single-center, randomized, double-masked, parallel study. In this clinical study, the efficacy comparison between Pataday® Once Daily Relief Extra Strength and Claritin® Tablets 24-Hour will be made using the Ora-CAC model, a validated clinical model accepted by regulatory agents for assessing the efficacy of products on the signs and symptoms of allergic conjunctivitis.

NCT ID: NCT05265897 Completed - Lung Cancer Clinical Trials

Improving Implementation of Lung Cancer Screening in Diverse Populations II

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

This project assesses the feasibility, appropriateness, and acceptability of a "Commonly Asked Questions after Lung Cancer Screening" (CAQ) informational document that the investigators created, resulting from patient and provider discussion in focus groups and interviews. If effective, the CAQ may be a new tool to help improve patient understanding of LCS results and adherence to follow-up recommendations.